tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ANNX Stock Latest News

Annexon participates in a conference call with JPMorgan
The FlyAnnexon participates in a conference call with JPMorgan
1M ago
ANNX
Annexon Biosciences Faces Financial Risks Amid Global Trade Challenges
PremiumCompany Announcements
Annexon Biosciences Faces Financial Risks Amid Global Trade Challenges
2M ago
ANNX
Promising Outlook for Annexon Biosciences: Buy Rating Backed by Strong Pipeline and Financial Stability
PremiumRatings
Promising Outlook for Annexon Biosciences: Buy Rating Backed by Strong Pipeline and Financial Stability
2M ago
ANNX
Annexon Biosciences Reports Q2 2025 Financial Results
PremiumCompany Announcements
Annexon Biosciences Reports Q2 2025 Financial Results
2M ago
ANNX
Annexon reports Q2 EPS (34c), consensus (36c)
PremiumThe Fly
Annexon reports Q2 EPS (34c), consensus (36c)
2M ago
ANNX
Annexon reports Q2 EPS (34c), consensus (36c)
PremiumThe FlyAnnexon reports Q2 EPS (34c), consensus (36c)
2M ago
ANNX
Annexon completes enrollment in Phase 3 ARCHER II trial
Premium
The Fly
Annexon completes enrollment in Phase 3 ARCHER II trial
3M ago
ANNX
Annexon tells Wells Fargo doctor tweet not factural
Premium
The Fly
Annexon tells Wells Fargo doctor tweet not factural
4M ago
ANNX
Annexon Biosciences Holds Annual Stockholders Meeting
PremiumCompany Announcements
Annexon Biosciences Holds Annual Stockholders Meeting
5M ago
8K
ANNX
Annexon Biosciences: Promising Pipeline and Strategic Developments Reinforce Buy Rating
PremiumRatings
Annexon Biosciences: Promising Pipeline and Strategic Developments Reinforce Buy Rating
5M ago
ANNX
Annexon presents tanruprubart data at PNS annual meeting
PremiumThe Fly
Annexon presents tanruprubart data at PNS annual meeting
5M ago
ANNX
Buy Rating on Annexon Biosciences: Promising ANX005 for GBS and Strategic Path to FDA Approval
PremiumRatings
Buy Rating on Annexon Biosciences: Promising ANX005 for GBS and Strategic Path to FDA Approval
5M ago
ANNX
Annexon price target lowered to $14 from $20 at H.C. Wainwright
PremiumThe FlyAnnexon price target lowered to $14 from $20 at H.C. Wainwright
5M ago
ANNX
Annexon Biosciences: Promising Growth Potential with Key Catalysts and Strategic FDA Interactions
Premium
Ratings
Annexon Biosciences: Promising Growth Potential with Key Catalysts and Strategic FDA Interactions
5M ago
ANNX
Annexon Biosciences: Buy Rating Driven by Regulatory Milestones and Promising Pipeline Developments
Premium
Ratings
Annexon Biosciences: Buy Rating Driven by Regulatory Milestones and Promising Pipeline Developments
5M ago
ANNX
Annexon Biosciences Reports Increased Q1 2025 Losses
PremiumCompany Announcements
Annexon Biosciences Reports Increased Q1 2025 Losses
5M ago
ANNX
Annexon reports Q1 EPS (37c), consensus (29c)
PremiumThe Fly
Annexon reports Q1 EPS (37c), consensus (29c)
6M ago
ANNX
Annexon sees cash runway into 2H26
PremiumThe Fly
Annexon sees cash runway into 2H26
6M ago
ANNX
Annexon Biosciences’ ANX005: Promising Phase III Results and Strategic Initiatives Drive Buy Rating
PremiumRatings
Annexon Biosciences’ ANX005: Promising Phase III Results and Strategic Initiatives Drive Buy Rating
7M ago
ANNX
Annexon announces tanruprubart trial meets primary endpoint
PremiumThe FlyAnnexon announces tanruprubart trial meets primary endpoint
7M ago
ANNX
Needham healthcare analysts hold analyst/industry conference call
Premium
The Fly
Needham healthcare analysts hold analyst/industry conference call
7M ago
JNJ
NVS
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
7M ago
PLX
SLS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >